Shares of Varian Medical Systems (NYSE:VAR) and Elekta AB (STO:EKTA B) gained yesterday after news broke that rival Siemens (NYSE:SI) plans to scale back its radiation therapy business.
Elekta
Getinge Group pays $680 million for Atrium Medical | Acquisitions Roundup
Sweden-based Getinge Group announced a definitive agreement to acquire soft tissue reinforcement technology developer Atrium Medical for $680 million.
Atrium will operate as an independent, self-contained unit of Getinge subsidiary Maquet Cardiovascular and will continue to be led by current Atrium president, Trevor Carlton, according to a press release.
DJO Global’s executive vice president resigns | Personnel Moves
Medical device maker DJO Global, Inc. announced that its executive vice president of U.S. commercial operations, Andrew Holman, will leave the company “to pursue other opportunities.”
Newly minted DJO president & CEO Mike Mogul will assume responsibility for the San Diego, Calif.-based company’s U.S. commercial activities.
Elekta Completes the Acquisition of Nucletron
Elekta AB (publ) (STO:EKTAB) today announced it has successfully
completed its acquisition of Nucletron, the world leader in
brachytherapy treatment planning and delivery. Through the combination
Elekta will offer a complete range of radiotherapy planning and delivery
technologies. As the market leader in Europe and with strong positions
in North America and Asia, Elekta will enhance the combined ability to
meet the clinical needs of cancer patients and health care providers
throughout the world.
“Now we have successfully completed the acquisition and we are very
enthusiastic about building a broader, stronger and highly complementary
range of cutting-edge cancer care solutions”
